MENU
PLRX
AS OF
Nov 13 closing price
Price
$1.72
Change
-$0.08 (-4.44%)
Capitalization
106M
109 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pliant Therapeutics (PLRX) Earnings Date & Reports

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases... Show more

A.I. Advisor
published Earnings

PLRX is expected to report earnings to fall 1.35% to -42 cents per share on March 03

Pliant Therapeutics PLRX Stock Earnings Reports
Q4'25
Est.
$-0.42
Q3'25
Beat
by $0.13
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.15
Q4'24
Beat
by $0.17
The last earnings report on November 06 showed earnings per share of -43 cents, beating the estimate of -56 cents. With 434.79K shares outstanding, the current market capitalization sits at 106.00M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PLRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PLRX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for PLRX
A.I. Advisor
published General Information

General Information

a company which engages in the business of developing and commercializing novel therapies for fibrotic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
260 Littlefield Avenue
Phone
+1 650 481-6770
Employees
158
Web
https://www.pliantrx.com